NeoPharm CO., LTD. (KOSDAQ: 092730)
South Korea flag South Korea · Delayed Price · Currency is KRW
23,400
+200 (0.86%)
Sep 11, 2024, 3:19 PM KST

NeoPharm CO., LTD. Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Operating Revenue
107,85897,10585,03387,93181,62583,240
Upgrade
Other Revenue
-0--0---
Upgrade
Revenue
107,85897,10585,03387,93181,62583,240
Upgrade
Revenue Growth (YoY)
20.79%14.20%-3.30%7.72%-1.94%25.60%
Upgrade
Cost of Revenue
41,21531,72026,65325,54422,98423,136
Upgrade
Gross Profit
66,64265,38558,38062,38658,64260,104
Upgrade
Selling, General & Admin
37,49036,27632,98436,02232,99133,958
Upgrade
Research & Development
2,8382,6472,8542,9352,8022,518
Upgrade
Operating Expenses
41,74940,07836,94139,95536,74037,144
Upgrade
Operating Income
24,89325,30721,43922,43121,90222,961
Upgrade
Interest Expense
-37.35-21.32-8.84-38.46-56.37-17.17
Upgrade
Interest & Investment Income
4,3104,5882,0771,1771,3661,252
Upgrade
Currency Exchange Gain (Loss)
648.97-117.74205.38662.9-126.0424.92
Upgrade
Other Non Operating Income (Expenses)
-737.19-362.95-376.73-430.38-138.91-424.3
Upgrade
EBT Excluding Unusual Items
29,07729,39323,33523,80122,94723,796
Upgrade
Gain (Loss) on Sale of Investments
-2.76-2.76-48.48--
Upgrade
Gain (Loss) on Sale of Assets
-14.46-3.7-6.05-3.23-10.81-7.28
Upgrade
Asset Writedown
-1.58-13.47-6.23-11.07--250.66
Upgrade
Other Unusual Items
-----2.93
Upgrade
Pretax Income
29,05829,37323,32323,83622,93623,541
Upgrade
Income Tax Expense
6,1296,1606,2966,1224,8054,296
Upgrade
Net Income
22,92923,21317,02717,71318,13119,245
Upgrade
Net Income to Common
22,92923,21317,02717,71318,13119,245
Upgrade
Net Income Growth
15.91%36.33%-3.87%-2.30%-5.79%25.22%
Upgrade
Shares Outstanding (Basic)
888887
Upgrade
Shares Outstanding (Diluted)
888888
Upgrade
Shares Change (YoY)
-0.01%---0.95%4.38%5.80%
Upgrade
EPS (Basic)
2932.142968.152177.202264.942318.342569.66
Upgrade
EPS (Diluted)
2931.992968.002177.002264.942296.002544.00
Upgrade
EPS Growth
15.94%36.33%-3.88%-1.35%-9.75%18.33%
Upgrade
Free Cash Flow
-3,4103,41117,70721,36116,78813,322
Upgrade
Free Cash Flow Per Share
-436.10436.122264.082731.382126.361761.20
Upgrade
Dividend Per Share
750.000750.000700.000700.000650.000750.000
Upgrade
Dividend Growth
7.14%7.14%0%7.69%-13.33%15.38%
Upgrade
Gross Margin
61.79%67.33%68.66%70.95%71.84%72.21%
Upgrade
Operating Margin
23.08%26.06%25.21%25.51%26.83%27.58%
Upgrade
Profit Margin
21.26%23.90%20.02%20.14%22.21%23.12%
Upgrade
Free Cash Flow Margin
-3.16%3.51%20.82%24.29%20.57%16.00%
Upgrade
EBITDA
27,23026,98023,05523,93123,39624,169
Upgrade
EBITDA Margin
25.25%27.78%27.11%27.22%28.66%29.04%
Upgrade
D&A For EBITDA
2,3381,6731,6161,5001,4941,209
Upgrade
EBIT
24,89325,30721,43922,43121,90222,961
Upgrade
EBIT Margin
23.08%26.06%25.21%25.51%26.83%27.58%
Upgrade
Effective Tax Rate
21.09%20.97%27.00%25.69%20.95%18.25%
Upgrade
Advertising Expenses
-12,40811,53314,69512,68611,410
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.